blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3024447

EP3024447 - PHARMACEUTICAL COMPOSITION FOR ORAL INSULIN ADMINISTRATION COMPRISING A TABLET CORE AND AN ANIONIC COPOLYMER COATING [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  16.06.2017
Database last updated on 28.09.2024
Most recent event   Tooltip16.06.2017Withdrawal of applicationpublished on 19.07.2017  [2017/29]
Applicant(s)For all designated states
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
[2016/22]
Inventor(s)01 / HOVGAARD, Lars
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
02 / REFSGAARD, Hanne
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
03 / KJELDSEN, Thomas Børglum
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
04 / MADSEN, Peter
Novo Nordisk A/S
Novo Allé
2880 Bagsværd / DK
 [2016/22]
Application number, filing date14746972.011.07.2014
[2016/22]
WO2014EP64927
Priority number, dateEP2013017778624.07.2013         Original published format: EP 13177786
EP2014016419810.04.2014         Original published format: EP 14164198
[2016/22]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015010927
Date:29.01.2015
Language:EN
[2015/04]
Type: A1 Application with search report 
No.:EP3024447
Date:01.06.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 29.01.2015 takes the place of the publication of the European patent application.
[2016/22]
Search report(s)International search report - published on:EP29.01.2015
ClassificationIPC:A61K9/28, A61K31/00
[2016/22]
CPC:
A61K31/00 (EP,US); A61K9/2846 (US); A61K38/28 (US);
A61K9/2013 (US); A61K9/284 (EP,US); A61K9/2886 (US);
A61P3/10 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/22]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG ZUR ORALEN INSULINVERABREICHUNG MIT EINEM TABLETTENKERN UND EINER ANIONISCHEN COPOLYMERBESCHICHTUNG[2016/22]
English:PHARMACEUTICAL COMPOSITION FOR ORAL INSULIN ADMINISTRATION COMPRISING A TABLET CORE AND AN ANIONIC COPOLYMER COATING[2016/22]
French:COMPOSITION PHARMACEUTIQUE POUR ADMINISTRATION ORALE D'INSULINE COMPRENANT UN COEUR DE COMPRIMÉ ET UN ENROBAGE DE COPOLYMÈRE ANIONIQUE[2016/22]
Entry into regional phase24.02.2016National basic fee paid 
24.02.2016Designation fee(s) paid 
24.02.2016Examination fee paid 
Examination procedure24.02.2016Examination requested  [2016/22]
21.10.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
27.12.2016Amendment by applicant (claims and/or description)
12.06.2017Application withdrawn by applicant  [2017/29]
Request for further processing for:27.12.2016Request for further processing filed
27.12.2016Full payment received (date of receipt of payment)
Request granted
31.01.2017Decision despatched
02.01.2017Request for further processing filed
02.01.2017Full payment received (date of receipt of payment)
Request granted
24.01.2017Decision despatched
Fees paidRenewal fee
01.08.2016Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]CA2187741  (YAMANOUCHI PHARMA CO LTD [JP]) [I] 1-15 * example 12 * * example - * * claim - *;
 [I]US2007087957  (KIDRON MIRIAM [US]) [I] 1-15 * paragraphs [0026] - [0028] - [0034] - [0039] - [0077] - [89. 098] - [0014] * * example -; claim - *;
 [I]US2007238707  (LEONARD THOMAS W [US]) [I] 1-15 * paragraphs [0040] , [0048] , [0091] , [0136] - [0144] *;
 [I]WO2011084618  (NOD PHARMACEUTICALS INC [US], et al) [I] 1-15 * paragraphs [0050] , [0118] * * examples 9,10,15 * * claim - *;
 [I]US2013058999  (FOEGER FLORIAN ANDERS [DK]) [I] 1-15* paragraphs [0045] , [0069] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.